FDA recall Z-2452-2021

Cellex · Class II · device

Product

Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"

Reason for recall

The kit does not have an emergency use authorization (EUA).

Distribution

US Nationwide distribution in the states of CA, FL, TX, and WI.

Key facts

Status
Ongoing
Initiation date
2021-03-01
Report date
2021-09-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Morrisville, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2452-2021